The body adapts more gradually
Semaglutide, originally developed to treat type 2 diabetes, has gained approval for weight management due to its remarkable efficacy in promoting weight loss
a Key inclusion criteria for STEP 1, 35 and 8 trials were age 18 years, BMI 30 kg/m 2 or 27 kg/m 2 with 1 weightrelated comorbidity (treated or untreated): hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease, history of at least one selfreported unsuccessful dietary effort to lose weight and no type 1 or type 2 diabetes
FDA is aware of compounded semaglutide products that are being marketed for weight loss, the agency said
Some pharmacies now offer compounds with three or four additives, semaglutide with pyridoxine plus B12 plus glycine, for example, attempting to address nausea, fatigue, and muscle preservation simultaneously in a single injection